Sources: 1BitterDB, 4ClinicalTrials, 7Cochrane Library, 10DGIdb, 14DrugBank, 29HMDB, 33IUPHAR, 46NDF-RT, 50Novoseek, 56PharmGKB, 68UMLSSee all MalaCards sources |
Drugs for Epidermolysis Bullosa (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 99)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Tetracycline | approved, vet_approved | Phase 4 | 105 | 60-54-8 | 5353990 | (-)-Tetracycline (4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide 60-54-8 64-75-5 (mono-hydrochloride) 6591-49-7 87128_FLUKA 87128_SIGMA AC-13151 AC1L1KAT AC1NQXT7 AC1NRDAM AC1NS4RQ AC1NSDX8 AC1NTUT2 AC1NUZHL AC1O52HS Abramycin Abricycline Achromycin Achromycin (naphthacene derivative) Achromycin V Achromycin, naphthacene derivative Agromicina Ambramicina Ambramycin Amycin Anhydrotetracycline BIDD:GT0653 BPBio1_000242 BSPBio_000220 BSPBio_001950 Bio-tetra Biocycline Bristaciclin Bristaciclin .alpha. Bristaciclina Bristacycline C06570 CHEBI:27902 CHEMBL1440 CID12309720 CID5280962 CID5289435 CID5353990 CID5359245 CID5388997 CID5412 CID5497101 CID6426717 Cefracycline Cefracycline suspension Centet (base) Ciclibion Copharlan Criseociclina Cyclomycin Cyclopar Cytome D00201 DB00759 Democracin Deschlorobiomycin DivK1c_000827 Dumocyclin EINECS 200-481-9 Enterocycline HMS2090B04 HSDB 3188 Hostacyclin IDI1_000827 KBio1_000827 KBio2_001514 KBio2_004082 KBio2_006650 KBio3_001450 KBioGR_000783 KBioSS_001514 LS-187078 LS-93869 Lemtrex (base) Lexacycline Limecycline Liquamycin Liquamycin (Veterinary) | Liquamycin, veterinary MLS000069728 Medocycline Mericycline Micycline MolPort-001-794-633 MolPort-003-983-460 MolPort-005-934-198 NCGC00161665-01 NINDS_000827 NSC 108579 NSC108579 Neocycline Omegamycin Orlycycline Panmycin Piracaps (base) Polycycline Polycycline (VAN) Polycycline (antibiotic) Polycycline, antibiotic Polyotic Prestwick0_000140 Prestwick1_000140 Prestwick2_000140 Prestwick3_000140 Purocyclina Resteclin Robitet Roviciclina SK-Tetracycline SMR000058220 SPBio_001457 SPBio_002159 STOCK1N-42738 Sanclomycine Solvocin Spectrum2_001329 Spectrum3_000565 Spectrum4_000352 Spectrum5_001112 Spectrum_001034 Sumycin Sumycin (TN) Sumycin syrup T-125 T3258_SIGMA Tetra-Co Tetrabon Tetrachel Tetraciclina Tetraciclina [INN-Spanish] Tetracycl Tetracyclin Tetracycline & VRC3375 Tetracycline (JAN/USP/INN) Tetracycline (internal use) Tetracycline Free Base Tetracycline HCl Tetracycline I Tetracycline II Tetracycline Monohydrochloride Tetracycline [USAN:INN:BAN:JAN] Tetracyclinum Tetracyclinum [INN-Latin] Tetracyn Tetradecin Tetrafil Tetraverine Tetrazyklin Topicycline Tsiklomistsin Tsiklomitsin Tétracycline UNII-F8VB5M810T UPCMLD-DP127 UPCMLD-DP127:001 UPCMLD-DP127:002 Veracin Vetacyclinum Vetquamycin-324 (free base) WLN: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 MQ M1 RQ component of Tetrastatin methyl-1,11-dioxo-2-naphthacenecarboxamide nchembio.273-comp1 nchembio.289-comp1 tetracycline |
| | 2 | | Morphine | approved, investigational | Phase 4 | 1007 | 57-27-2 | 5288826 | (-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (-)-Heroin hydrochloride (-)-Morphine (-)Morphine sulfate (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol (5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol (5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL (7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol (−)-morphine 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol 4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol 4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol 47106-99-0 57-27-2 6211-15-0 (sulfate (2:1) (salt) pentahydrate) 64-31-3 64-31-3 (sulfate (2:1) (salt) anhydrous) 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol 7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol 8053-16-5 85201-37-2 Apokyn Astramorph PF Avinza BIDD:GT0147 C01516 CCRIS 5762 CHEBI:17303 CHEMBL70 CID5288826 Cube juice D-(-)-Morphine DB00295 DEA No. 9300 DepoDur Depodur Diacetylmorphine hydrochloride Diamorphine hydrochloride Dolcontin Dreamer Dulcontin Duramorph PF Duromorph EINECS 200-320-2 Epimorph HSDB 2134 Hard stuff Heroin hydrochloride Heroine hydrochloride Hocus | Infumorph Kadian LS-91748 M-Eslon M.O.S MOI MORPHINE SULFATE MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE MS Contin MS/L MS/S MSIR Meconium MolPort-003-849-273 Morfina Morfina [Italian] Morphia Morphin Morphin [German] Morphina Morphina [Italian] Morphine Extra-Forte Morphine Forte Morphine H.P Morphine Sulfate Morphine [BAN] Morphinism Morphinum Morphitec Morphium Morpho Moscontin Ms Contin Ms Emma NSC11441 Nepenthe O,O'-Diacetylmorphine hydrochloride OMS Concentrate Oramorph SR Ospalivina RMS RMS Uniserts Rescudose Roxanol Roxanol 100 Roxanol UD SDZ 202-250 SDZ202-250 Statex Statex Drops Statex SR UNII-76I7G6D29C Unkie l-Morphine morfina morphine nchembio.317-comp1 nchembio.64-comp1 |
| | 3 | | Peripheral Nervous System Agents | | Phase 4, Phase 2 | 23689 | | | | 4 | | Anti-Bacterial Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 11226 | | | | 5 | | Anti-Infective Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 22062 | | | | 6 | | Analgesics, Opioid | | Phase 4 | 3238 | | | | 7 | | Narcotics | | Phase 4 | 3646 | | | | 8 | | Analgesics | | Phase 4 | 11733 | | | | 9 | | Central Nervous System Depressants | | Phase 4 | 13403 | | | | 10 | | Erythromycin | approved, vet_approved | Phase 3 | 99 | 114-07-8 | 12560 | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione ,10-dione 114-07-8 3''-O-demethylerythromycin 374700-25-1 45673_FLUKA 45674_FLUKA 79235-06-6 82343-12-2 A/T/S AC-12744 AC1L1FIQ AC1L1QK7 AC1L1ZUR AC1O8PVA AC1Q2UA1 AC1Q6O1S AI3-50138 AR-1A4414 AR-1H0723 Abboticin Abomacetin Acneryne Acnesol Ak-Mycin Ak-mycin Akne Cordes Losung Akne-Mycin Akne-mycin (TN) Aknederm Ery Gel Aknemycin Aknin AustriaS BB_NC-1332 BIDD:GT0017 BPBio1_000312 BSPBio_000282 BSPBio_002480 Benzamycin Benzamycin Pak Bristamycin C-Solve-2 C01912 C37H67NO13 CCRIS 9078 CHEBI:42355 CHEMBL532 CID12560 CID3255 CID6713919 CID8233 D00140 DB00199 Del-Mycin Derimer Deripil DivK1c_000294 DivK1c_000397 DivK1c_000702 Dotycin Dumotrycin E- mycin, Erycin, Robimysin E-Base E-Base (base) E-Glades E-Mycin E-Mycin (base) E-Solve 2 E0751 E0774_SIAL E5389_SIGMA E6376_SIAL E7904_SIGMA EINECS 204-040-1 EM EMU ERY ERYC ERYC (base) ERYTHROMYCIN STEARATE ETS Emgel Emu-V Emu-Ve Emuvin Emycin Endoeritrin Erecin Erimycin-T Erisone Eritomicina Eritrocina Eritromicina Eritromicina [INN-Spanish] Ermycin Eros Ery-B Ery-Diolan Ery-Sol Ery-Tab Ery-Tab (base) Ery-maxin Eryacne Eryacnen Eryc Eryc (TN) Eryc 125 Eryc Sprinkles Eryc-125 Eryc-250 Erycen Erycette Erycin Erycinum Eryderm Erydermer Erygel Erygel (TN) Eryhexal Erymax Erymed Erypar Erysafe Erytab Erythra-Derm Erythro Erythro-Statin Erythro-Teva Erythrocin Erythrocin Stearate Erythroderm Erythrogran Erythroguent Erythromast 36 Erythromid Erythromycin Erythromycin & VRC3375 Erythromycin (JP15/USP/INN) | Erythromycin A Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279 Erythromycin B Erythromycin C Erythromycin Lactate Erythromycin Ointment Erythromycin Stearate Erythromycin [INN:BAN:JAN] Erythromycin base Erythromycin estolate Erythromycin ethylsuccinate Erythromycin glucoheptonate Erythromycin intravenous Erythromycin lactobionate Erythromycin oxime Erythromycin sodium lauryl sulfate Erythromycin, compd. with monododecyl sulfate, sodium salt Erythromycine Erythromycine [INN-French] Erythromycinum Erythromycinum [INN-Latin] Erytop Erytrociclin Ethril 250 HMS1568O04 HMS1920M04 HMS2091D05 HMS500O16 HSDB 3074 I06-0245 IDI1_000294 IDI1_000397 IDI1_000702 Ilocaps Ilosone Ilosone (estolate) Iloticina Ilotycin Ilotycin Gluceptate Ilotycin T.S Ilotycin T.S. Inderm Inderm Gel IndermRetcin KBio1_000294 KBio1_000397 KBio1_000702 KBio2_000555 KBio2_001139 KBio2_003123 KBio2_003707 KBio2_005691 KBio2_006275 KBioGR_001175 KBioSS_000555 KBioSS_001139 KST-1A8261 Kesso-Mycin LMPK04000006 LS-187077 LS-64648 Latotryd Lederpax MLS001066618 Mephamycin Mercina MolPort-000-772-161 MolPort-002-507-378 MolPort-003-933-429 N-Methylerythromycin A NCGC00179619-01 NCI-C55674 NINDS_000294 NINDS_000397 NINDS_000702 NSC 55929 NSC55929 Oftalmolosa Cusi Eritromicina Oftamolets PCE Dispertab (base) Paediathrocin Pantoderm Pantodrin Pantomicina Pce Pce (TN) Pfizer-e Pharyngocin Prestwick0_000151 Prestwick1_000151 Prestwick2_000151 Prestwick3_000151 Prestwick_205 Primacine Propiocine Proterytrin R-P Mycin Retcin Robimycin Romycin SBB057401 SMP1_000119 SMR000544946 SPBio_000778 SPBio_001226 SPBio_002221 SPECTRUM1500280 STK249736 Sans-acne Sansac Serp-AFD Skid Gel E Spectrum2_000759 Spectrum2_001263 Spectrum4_000538 Spectrum5_001596 Spectrum_000115 Spectrum_000659 Staticin Staticin (TN) Stiemicyn Stiemycin Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin T-Stat T-stat (TN) Taimoxin-F Theramycin Z Tiloryth Tiprocin Torlamicina UNII-63937KV33D Udima Ery Gel Wemid Wyamycin S adecane-2,10-dione (non-preferred name) bmse000664 erythro erythromycin nchembio.285-comp13 érythromycine |
| | 11 | | Gastrointestinal Agents | | Phase 3 | 8402 | | | | 12 | | Erythromycin stearate | | Phase 3 | 99 | | | | 13 | | Erythromycin Ethylsuccinate | | Phase 3 | 99 | | | | 14 | | Erythromycin Estolate | | Phase 3 | 99 | | | | 15 | | Sunflower | Nutraceutical | Phase 3 | 112 | | | | 16 | | Tacrolimus | approved, investigational | Phase 2, Early Phase 1 | 1102 | 104987-11-3 | 445643, 439492 | (-)-FK 506 (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone 104987-11-3 109581-93-3 (Hydrate) 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone, 3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN AC-1182 AC1L1K7H AC1L97GB AC1L9IBU AKOS005145901 Advagraf Ambap104987-11-3 Ambap5429 Anhydrous tacrolimus BCBcMAP01_000194 BRD-K35452788-001-02-1 BSPBio-001279 BSPBio_001279 Bio-0921 Bio2_000470 Bio2_000950 C01375 C44H69NO10 CCRIS 7124 CHEBI:100924 CHEBI:61049 CHEMBL1200738 CID11158639 CID11556866 CID439492 CID445643 CID5372 CID5472317 CID6426916 CID6436007 CID6473866 CID6536850 CID6610362 CID6912836 CID9832283 CID9853905 CID9918805 CID9940643 CID9963169 CPD-10016 CPD000466356 D08556 DB00864 DivK1c_001040 FK 506 FK-506 FK5 FK506 FR 900506 FR-900506 | FR900506 FT-0082660 Fk-506 Fujimycin Graceptor HMS1362O21 HMS1792O21 HMS1990O21 HMS2051C18 HMS2093M19 HMS503O21 IDI1_001040 IDI1_002225 K506 KBio1_001040 KBio2_000619 KBio2_003187 KBio2_005755 KBio3_001097 KBio3_001098 KBioGR_000619 KBioSS_000619 L 679934 L-679934 LCP-Tacro LMPK04000003 LS-64247 MLS000759471 MLS001424054 Modigraf MolPort-003-666-518 NCGC00163470-01 NCGC00163470-02 NCGC00163470-03 NCGC00163470-04 NCGC00179232-01 NChemBio.2007.16-comp1 NINDS_001040 NSC717865 Prograf Prograf (TN) Protopic Protopy S5003_Selleck SAM001246677 SMR000466356 Tacarolimus Tacrolimus (INN) Tacrolimus (Prograf?) Tacrolimus (anhydrous) Tacrolimus anhydrous Tacrolimus hydrate Tacrolimus, anhydrous Tsukubaenolide UNII-Y5L2157C4J nchembio.2007.23-comp2 tacrolimus tacrolimus hydrate | |
| | 17 | | Fludarabine | approved | Phase 2, Early Phase 1 | 1154 | 21679-14-1, 75607-67-9 | 30751 | (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 2-F-ARAA 2-F-ara-A 2-Fluoro Ara-A 2-Fluoro-9-beta-D-arabinofuranosyladenine 2-fluoro ARA-A 21679-14-1 9-beta-D-Arabinofuranosyl-2-fluoroadenine 9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI) AC1LCW8I AC1Q51CF C10H12FN5O4 CCRIS 3382 CHEMBL1568 CID657237 CPD000058874 D07966 EINECS 244-525-5 F-Ara-A FAMP FT-0082766 FaraA Fludara Fludara, Fludarabine | Fludarabina Fludarabina [Spanish] Fludarabine Fludarabine (INN) Fludarabine 5'-monophosphate Fludarabine [INN] Fludarabine monophosphate Fludarabine phosphate Fludarabinum Fludarabinum [Latin] Fludura Fluradosa Fluradosa (TN) HSDB 6964 I14-4978 LS-15061 MLS000028687 NSC 118218 NSC 118218H NSC-118218 S1491_Selleck SAM002548956 SMR000058874 SQ Fludarabine UNII-1X9VK9O1SC UNII-P2K93U8740 ZINC04216238 | |
| | 18 | | Acetylcholine | approved | Phase 2 | 805 | 51-84-3 | 187 | ACh Acetyl choline ion Acetylcholine Chloride Acetylcholine cation | Acetylcholinium: acetyl-Choline Choline acetate Choline acetate (ester) O-Acetylcholine acetylcholine chloride | |
| | 19 | | Trimethoprim | approved, vet_approved | Phase 2 | 177 | 738-70-5 | 5578 | 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine 46984_FLUKA 46984_RIEDEL 5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine 738-70-5 92131_FLUKA 92131_SIGMA AB00052118 AB1004879 AC-13572 AC1L1KNQ AC1Q48DF AI3-52594 AKOS001650069 ARONIS24118 AZT + TMP/SMX (mixture) combination Abacin Abaprim Alcorim-F Alprim Anitrim Antrima Antrimox Apo-Sulfatrim BB_SC-2116 BIDD:GT0190 BPBio1_000215 BRD-K07208025-001-06-5 BRN 0625127 BSPBio_000195 BSPBio_002245 BW 56-72 BW 5672 BW-56-72 Bacdan Bacidal Bacide Bacin Bacta Bacterial Bacterial [Antibiotic] Bacticel Bactin Bactoprim Bactramin Bactrim Bactrim DS Bactrim Pediatric Baktar Bencole Bethaprim Biosulten Briscotrim C01965 CAS-738-70-5 CCRIS 2410 CHEBI:45924 CHEMBL22 CID5578 CPD0-1581 CPD000035999 Chemotrim Chemotrin Cidal Co-Trimoxizole Co-trimoxazole Colizole Colizole DS Comox Conprim Cotrim Cotrim D.S. Cotrimel D00145 D014295 DB00440 Deprim DivK1c_000589 Drylin Duocide EINECS 212-006-2 EU-0101271 Esbesul Espectrin Euctrim Eusaprim Exbesul Fectrim Fermagex Fortrim Futin Gantaprim Gantrim HMS1568J17 HMS1921I03 HMS2090D14 HMS2092A10 HMS501N11 HSDB 6781 I06-0086 IDI1_000589 Idotrim Ikaprim Imexim Instalac Ipral KBio1_000589 KBio2_000647 KBio2_003215 KBio2_005783 KBio3_001465 KBioGR_000863 KBioSS_000647 KSC-4-158 KUC103659N Kepinol Kombinax LS-1627 Lagatrim Lagatrim Forte Laratrim Lastrim Lidaprim Linaris Lopac-T-7883 Lopac0_001271 MLS000079023 MLS001201740 MLS002303068 Methoprim Metoprim Microtrim MolPort-001-826-685 Monoprim Monotrim Monotrimin NCGC00016055-01 NCGC00016055-02 NCGC00016055-06 NCGC00016055-12 NCGC00024707-01 NCGC00024707-03 NCGC00024707-04 NCGC00024707-05 NCGC00024707-06 NCGC00024707-07 NCGC00024707-08 NIH 204 | NIH 204 (VAN) NINDS_000589 NSC 106568 NSC-106568 NSC106568 Nopil Novotrimel Omstat Oprea1_495058 Oraprim Pancidim Polytrim Prestwick0_000208 Prestwick1_000208 Prestwick2_000208 Prestwick3_000208 Prestwick_485 Priloprim Primosept Primsol Proloprim Proloprim (TN) Protrin Purbal Resprim Resprim Forte Roubac Roubal SAM002264649 SMP2_000262 SMR000035999 SPBio_000874 SPBio_002116 SPECTRUM1500595 STK177322 Salvatrim Septra Septra DS Septra Grape Septrin Septrin DS Septrin Forte Septrin S Setprin Sigaprim Sinotrim Smz-Tmp Spectrum2_000937 Spectrum3_000643 Spectrum4_000372 Spectrum5_001559 Spectrum_000167 Stopan Streptoplus Sugaprim Sulfamar Sulfamethoprim Sulfamethoprim-DS Sulfamethoxazole & Trimethoprim Sulfatrim Sulfatrim Pediatric Sulfatrim-DS Sulfatrim-SS Sulfotrim Sulfoxaprim Sulmeprim Sulmeprim Pediatric Sulprim Sulthrim Sultrex Sumetrolim Supracombin Suprim Syraprim T 7883 T2286 T7883_SIGMA TCMDC-125538 TL8005108 TMP/SMX (MIXTURE)) Teleprim Thiocuran Tiempe Tmp-Ratiopharm Tocris-0650 Toprim Trigonyl Trimanyl Trimesulf Trimeth/Sulfa Trimethioprim Trimethopim(TMP) Trimethoprim Trimethoprim & VRC3375 Trimethoprim (JAN/USP/INN) Trimethoprim [USAN:BAN:INN:JAN] Trimethoprime Trimethoprime [INN-French] Trimethoprimum Trimethoprimum [INN-Latin] Trimethopriom Trimetoprim Trimetoprim [DCIT] Trimetoprim [Polish] Trimetoprima Trimetoprima [INN-Spanish] Trimexazole Trimexol Trimez-IFSA Trimezol Trimogal Trimono Trimopan Trimpex Trimpex (TN) Trimpex 200 Triméthoprime Triprim Trisul Trisulcom Trisulfam Trisural U-Prin UNII-AN164J8Y0X UPCMLD-DP132 UPCMLD-DP132:001 Unitrim Uretrim Uro-D S Uro-Septra Urobactrim Uroplus Uroplus DS Uroplus SS Utetrin Velaten WLN: T6N CNJ BZ DZ E1R CO1 DO1 EO1 WR 5949 Wellcoprim Wellcoprin Xeroprim ZINC06627681 Zamboprim component of Bactrim component of Septra nchembio.108-comp1 nchembio.215-comp11 nchembio.221-comp23 trimethoprim | |
| | 20 | | Methoxsalen | approved | Phase 2 | 38 | 298-81-7 | 4114 | 12692-94-3 298-81-7 5-19-06-00015 (Beilstein Handbook Reference) 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, .delta.-lactone 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, delta-lactone 6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone 7-Furocoumarin 8 MOP 8 Methoxypsoralen 8-METHOXYPSORALEN + UVA (SEE ALSO C55903) 8-MOP 8-MP 8-Methoxy 8-Methoxy(furano-3'.2':6.7-coumarin) 8-Methoxy-(furano-3'.2':6.7-coumarin) 8-Methoxy-2',3',6,7-furocoumarin 8-Methoxy-4',5',6,7-furocoumarin 8-Methoxy-4',5':6,7-furocoumarin 8-Methoxy-[furano-3'.2':6.7-coumarin] 8-Methoxyfuranocoumarin 8-Methoxypsoralen 8-Methoxypsoralen with ultraviolet A therapy 8-Methoxypsoralene 8-methoxyfuranocoumarins 8-methoxyfurocoumarins 8MO 8MOP 9-(methyloxy)-7H-furo[3,2-g]chromen-7-one 9-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one 9-Methoxy-7H-furo(3,2-g)benzopyran-7-one 9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one 9-Methoxy-7H-furo[3,2-g]chromen-7-one 9-Methoxyfuro(3,2-g)chromen-7-one 9-Methoxyfuro[3,2-g][1]benzopyran-7-one 9-Methoxypsoralen 9-metho xy-7H-furo(3,2-g)benzopyran-7-one 9-methoxyfuro[3,2-g]chromen-7-one A1783/0075596 AC-4259 AC1L1HFY ACon1_000174 AKOS000277012 Ammodin Ammoidin BPBio1_000680 BRD-K63430059-001-03-2 BRD-K63430059-001-06-5 BRN 0196453 BSPBio_000618 BSPBio_001997 Boehringer Ingelheim Brand of Methoxsalen C01864 CAS-298-81-7 CCRIS 2083 CHEBI:18358 CHEBI:52028 CHEMBL416 CID4114 CPD-13042 CPD000071170 Canderm Brand of Methoxsalen Chinoin Brand of Methoxsalen D00139 D008730 DB Brand of Methoxsalen DB00553 Delta Brand of Methoxsalen Deltasoralen Dermatech Brand of Methoxsalen Dermox DivK1c_000763 EINECS 206-066-9 FT-0082222 Galderma Brand of Methoxsalen Geroxalen HMS1569O20 HMS1920N05 HMS2091D20 HMS502G05 HSDB 2505 I06-0695 ICN Brand 1 of Methoxsalen ICN Brand 2 of Methoxsalen ICN Brand 3 of Methoxsalen IDI1_000763 Jsp005650 KBio1_000763 KBio2_001503 KBio2_004071 KBio2_006639 KBio3_001497 KBioGR_000543 KBioSS_001503 LS-68 M3501_FLUKA M3501_SIAL MEGxp0_000095 MLS000062633 | MLS002303011 Meladinin Meladinin (VAN) Meladinina Meladinine Meladoxen Meloxine Methoxa Dome Methoxa-Dome Methoxalen Methoxaten Methoxsalen Methoxsalen (JP15/USP) Methoxsalen Canderm Brand Methoxsalen Chinoin Brand Methoxsalen Delta Brand Methoxsalen Dermatech Brand Methoxsalen Mex-America Brand Methoxsalen Sanofi-Synthelabo Brand Methoxsalen [BAN:JAN] Methoxsalen plus ultraviolet radiation Methoxsalen with ultra-violet A theraphy Methoxy-8-psoralen Mex America Brand of Methoxsalen Mex-America Brand of Methoxsalen MolPort-000-696-480 Méthoxsalène NCGC00016418-01 NCGC00060938-02 NCGC00060938-03 NCGC00060938-04 NCGC00060938-05 NCGC00060938-06 NCGC00178871-01 NCGC00178871-02 NCGC00178871-03 NCI-C55903 NCI60_004085 NINDS_000763 NSC 45923 NSC45923 New-Meladinin O-Methylxanthotoxol O-methylxanthotoxol OXSORALEN (TN) Oprea1_166319 Oxoralen Oxsoralen Oxsoralen Lotion Oxsoralen Ul tra Oxsoralen Ultra Oxsoralen lotion Oxsoralen-Ultra Oxsoralen-ultra Oxypsoralen Prestwick0_000479 Prestwick1_000479 Prestwick2_000479 Prestwick3_000479 Prestwick_661 Proralone-Mop Proralone-mop Psoralen-Mop Psoralen-mop Psoralon-MOP Puvalen Puvamet S1952_Selleck SAM002548974 SDCCGMLS-0042377.P002 SMR000071170 SPBio_001004 SPBio_002557 SPECTRUM1500400 STK735539 STOCK1N-03091 Sanofi Synthelabo Brand of Methoxsalen Sanofi-Synthelabo Brand of Methoxsalen Spectrum2_001052 Spectrum3_000499 Spectrum4_000052 Spectrum5_001891 Spectrum_001023 UNII-U4VJ29L7BQ Ultra Mop Ultra mop Ultramop Ultramop Lotion Uvadex WLN: T C566 DO LVOJ BO1 X0009 XANTHOTOXIN Xanthotoxin Xanthotoxine Xanthoxin ZINC02548959 Zanthotoxin an 8-methoxyfurocoumarin methoxsalen | |
| | 21 | | Lenograstim | approved | Phase 2 | 1220 | 135968-09-1 | | G-CSF (CHO cell derived) Glycosylated recombinant G-CSF Glycosylated recombinant granulocyte colony stimulating factor | Granulocyte colony stimulating factor 3 (CHO cell derived) Granulocyte colony-stimulating factor lenograstim Lenograstim (genetical recombination) Lenograstim rDNA | |
| | 22 | | Methylprednisolone | approved, vet_approved | Phase 2 | 1193 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone |
| | 23 | | Prednisolone | approved, vet_approved | Phase 2 | 1193 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol | MLS001304083 MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 24 | | Mesna | approved | Phase 2 | 263 | 3375-50-6 | 598 | 2-Mercaptoethane 2-Mercaptoethanesulfonate 2-Mercaptoethanesulfonic acid 2-mercaptoethanesulfonic acid 2-mercaptoethanesulphonic acid 2-mercaptoethylsulfonate 2-sulfanylethylsulfonate | CoM Coenzima M Coenzym M Coenzyme M HS-CoM reduced CoM reduced coenzyme M β-mercaptoethanesulfonic acid | |
| | 25 | | Everolimus | approved | Phase 2 | 1940 | 159351-69-6 | 6442177 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy 07741_FLUKA 159351-69-6 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-Hydroxyethyl)rapamycin Afinitor CERTICAN(R) CHEMBL1201755 Certican D02714 DB01590 | Everolimus Everolimus (JAN/USAN/INN) Everolimus [USAN] LS-143292 MolPort-003-847-342 MolPort-003-925-588 NCGC00167512-01 NVP-RAD-001 RAD 001 RAD-001 RAD-001C RAD001 RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus S1120_Selleck SDZ-RAD UNII-9HW64Q8G6G Zortress everolimus |
| | 26 | | Mycophenolic acid | approved | Phase 2 | 952 | 24280-93-1 | 446541 | (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid Acide mycophenolique Acido micofenolico Acidum mycophenolicum | Melbex Micofenolico acido Mycophenoic acid Mycophenolate Mycophenolsäure Myfortic |
| | 27 | | Mycophenolate mofetil | approved, investigational | Phase 2 | 952 | 128794-94-5 | 5281078 | 115007-34-6 128794-94-5 140401-05-4 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E) AC-1562 AC1NQXZW AC1Q6O6X AR-1J6939 BB_NC-2566 C07908 C23H31NO7 CHEMBL1456 CID5281078 CellCept CellCept, RS 61443, TM-MMF, Mycophenolate mofetil Cellcept Cellcept (TN) D00752 DB00688 HMS2090A03 | HSDB 7436 I01-0898 I06-1947 LS-172272 LS-75572 ME-MPA MMF MMF CellCept(TM) MolPort-000-883-800 Munoloc Mycophenolate mofetil (JAN/USAN) Mycophenolic acid morpholinoethyl ester Mycophenylate mofetil NCGC00159459-02 NCGC00159459-03 NSC724229 R-99 RS 61443 RS-61443 RS-61443-190 S1501_Selleck TL8000648 TM-MMF UNII-9242ECW6R0 ZINC21297660 mycophenolate mofetil | |
| | 28 | | Benzocaine | approved | Phase 2 | 2016 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 29 | | Cyclophosphamide | approved, investigational | Phase 2 | 2935 | 50-18-0, 6055-19-2 | 2907 | (+-)-Cyclophosphamide (-)-Cyclophosphamide (RS)-Cyclophosphamide 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide 4-Hydroxy-cyclophosphan-mamophosphatide 50-18-0 60007-95-6 6055-19-2 (monohydrate) 75526-90-8 AC1L1EQQ AI3-26198 ASTA ASTA B518 Anhydrous cyclophosphamide Asta B 518 B 518 B-518 BRN 0011744 BSPBio_002099 Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester C 0768 C07888 C7H15Cl2N2O2P CB 4564 CB-4564 CCRIS 188 CHEBI:4027 CHEMBL32520 CHEMBL88 CID2907 CP CPA CTX CY Ciclofosfamida Ciclofosfamida [INN-Spanish] Ciclofosfamide Ciclophosphamide Ciclophosphamide [INN] Clafen Claphene Cycloblastin Cyclophosphamid Cyclophosphamide Cyclophosphamide (INN) Cyclophosphamide (TN) Cyclophosphamide (anhydrous form) Cyclophosphamide (anhydrous) Cyclophosphamide Monohydrate Cyclophosphamide Sterile Cyclophosphamide anhydrous Cyclophosphamide, (+-)-Isomer Cyclophosphamides Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan Cytoxan (TN) Cytoxan Lyoph D,L-Cyclophosphamide D07760 | DB00531 DivK1c_000246 EINECS 200-015-4 EU-0100238 Endoxan Endoxan R Endoxan-Asta Endoxana Endoxanal Endoxane Enduxan Genoxal HMS2090A12 HSDB 3047 Hexadrin IDI1_000246 KBio1_000246 KBio2_001338 KBio2_003906 KBio2_006474 KBio3_001319 KBioGR_000888 KBioSS_001338 LS-1302 LS-99787 Ledoxina Lopac-C-0768 Lopac0_000238 Lyophilized Cytoxan Mitoxan MolPort-001-783-420 N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide NCGC00015209-01 NCGC00015209-03 NCGC00015209-06 NCGC00091741-02 NCGC00091741-03 NCI-C04900 NCI60_002097 NINDS_000246 NSC 26271 NSC-26271 NSC26271 NSC273033 NSC273034 Neosar Occupation, cyclophosphamide exposure Procytox RCRA waste no. U058 Rcra Waste Number U058 Rcra waste number U058 Revimmune S1217_Selleck SK 20501 SPBio_001071 STK177249 STOCK2S-91217 Semdoxan Sendoxan Senduxan Spectrum2_001146 Spectrum3_000370 Spectrum4_000304 Spectrum5_000795 Spectrum_000858 UNII-6UXW23996M WLN: T6MPOTJ BO BN2G2G Zyklophosphamid Zyklophosphamid [German] bis(2-Chloroethyl)phosphami de cyclic propanolamide bis(2-Chloroethyl)phosphamide cyclic propanolamide ester cyclophosphamide |
| | 30 | | Miconazole | approved, investigational, vet_approved | Phase 2 | 3706 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Micantin (nitrate) Miconasil Nitrate | Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole | |
| | 31 | | Sirolimus | approved, investigational | Phase 2 | 1940 | 53123-88-9 | 5284616, 6436030, 46835353 | (-)-Rapamycin (-)-rapamycin 1fkb 1pbk 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 53123-88-9 A422989, NSC226080 AC-722 AC1L1JH9 AC1L7MJ9 AC1L9ZMV AY 22989 AY-22989 AY22989 Ambotz53123-88-9 Antibiotic AY 22989 BIDD:PXR0165 Bio1_000293 Bio1_000782 Bio1_001271 Bio2_000375 Bio2_000855 BiomolKI2_000084 C07909 C51H79NO13 CBiol_002007 CCRIS 9024 CHEBI:100923 CHEBI:9168 CHEMBL413 CID10213190 CID10795871 CID11949238 CID11959112 CID313006 CID478951 CID5040 CID5284616 CID5358081 CID5374464 CID5460439 CID5497196 CID5924240 CID6436030 CID6610270 CID6610346 CID6711160 CID6713081 CID9833581 CID9854379 CID9854380 CID9962926 CID9962928 D00753 DB00877 DE-109 DivK1c_006936 | FT-0082351 HMS2089A21 HSDB 7284 KBio1_001880 KBio2_000410 KBio2_002978 KBio2_005546 KBio3_000779 KBio3_000780 KBioGR_000410 KBioSS_000410 LCP-Siro LMPK06000003 LS-143290 MLS000028373 MS-R001 MolMap_000043 MolPort-003-959-433 NCGC00021305-05 NCI60_001851 NCIMech_000355 NSC 226080 NSC226080 Perceiva QTL1_000069 R0395_SIAL R0395_SIGMA RAP RAPA RPM Rapammune Rapamune Rapamune (TN) Rapamycin Rapamycin (TN) Rapamycin C-7, analog 4 Rapamycin Immunosuppressant Drug Rapamycin from Streptomyces hygroscopicus S1039_Selleck SIIA 9268A SILA 9268A SILA9268A SMP1_000255 SMR000058564 Sirolimus Sirolimus (RAPAMUNE) Sirolimus (USAN/INN) Sirolimus [USAN:BAN:INN] Sirolimus, Rapamune,Rapamycin SpecPlus_000840 UNII-W36ZG6FT64 UNM-0000358684 WY-090217 Wy 090217 heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy nchembio.100-comp4 nchembio.2007.42-comp2 nchembio.79-comp1 nchembio762-comp1 nchembio883-comp3 rapamycin sirolimus |
| | 32 | | Cyclosporine | approved, investigational, vet_approved | Phase 2 | 922 | 79217-60-0, 59865-13-3 | 5284373, 6435893 | 1c5f 1cyn 30024_FLUKA 30024_SIGMA 59865-13-3 79217-60-0 AC1L1EQW AC1NQXJE AC1NR4C4 AC1NUQK3 AC1NUZNC AC1O5KOG AC1Q2UDG Ambap59865-13-3 Ambotz59865-13-3 Antibiotic S 7481F1 BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA BPBio1_000496 BRD-A64290322-001-01-6 BRD-A69815203-001-04-3 BRD-K13533483-001-03-0 BSPBio_000450 BSPBio_001596 BSPBio_003186 C 3662 C05086 C1832_SIGMA C3662_SIGMA C62H111N11O12 CB-01-09 MMX CHEBI:106343 CHEBI:328305 CHEBI:4031 CHEMBL160 CHEMBL386389 CHEMBL532318 CID2909 CID5280754 CID5284373 CID5458585 CID5497195 CID6435893 CSA CYCLOSPORIN A (SEE ALSO TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A)) CYCLOSPORIN A, USP Ciclosporin Ciclosporin (JP15) Ciclosporina Ciclosporine Ciclosporinum Cipol N Cipol-N Consupren Consupren S CsA CsA & IFN.alpha. CyA Cyclokat Cyclosporin Cyclosporin A Cyclosporin A & IFN.alpha. Cyclosporin A Implant Cyclosporin A, Tolypocladium inflatum Cyclosporine (USP) Cyclosporine A Cyclosporine [USAN] D00184 DE-076 DivK1c_000871 EU-0100242 Equoral GNF-Pf-2808 Gengraf Gengraf (TN) HMS1569G12 HMS1791P18 HMS1921L20 HMS1989P18 HMS2089A09 HMS2092F06 HMS502L13 Helv Chim Acta 60: 1568 (1977) | I06-0379 I06-0966 IDI1_000871 KBio1_000871 KBio2_000780 KBio2_003348 KBio2_005916 KBio3_002686 KBioGR_001898 KBioSS_000780 LMPK14000003 LS-257 LS-58836 Lopac0_000242 MLS000028376 MLS001333756 MLS002153454 MLS002207033 Mitogard Modusik-A MolPort-000-760-988 MolPort-005-934-008 MolPort-006-705-994 NCGC00093704-01 NCGC00093704-02 NCGC00093704-03 NCGC00093704-04 NCGC00093704-05 NCGC00093704-06 NCGC00093704-07 NCGC00093704-08 NCGC00164258-01 NCGC00164258-02 NINDS_000871 NSC290193 Neoplanta Neoral Neoral (TN) NeuroSTAT Nova-22007 OL 27-400 OL-27400 OLO-400 Papilock Prestwick2_000435 Prestwick3_000435 Prestwick_731 Pulminiq Ramihyphin A Restasis Restasis (TN) S-Neoral S1514_Selleck SDZ-OXL 400 SMR000058578 SPBio_001467 SPECTRUM1502202 ST-603 Sandimmun Sandimmun Neoral Sandimmune Sandimmune (TN) Sandimmune, Gengraf, Restasis, Atopica, Sangcya, Cyclosporine Sang-2000 Sang-35 SangCyA Sangcya Sigmasporin Sigmasporin Microoral Spectrum2_001484 Spectrum3_001593 Spectrum4_001279 Spectrum5_001628 Spectrum_000300 TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A) Vekacia Zyclorin cyclophorine cyclosporin A cyclosporine from Tolypocladium inflatum (Trichoderma polysporin) nchembio.184-comp6 nchembio.301-comp5 nchembio.342-comp1 | |
| | 33 | | leucovorin | approved, Nutraceutical | Phase 2 | 3235 | 58-05-9 | 54575, 6560146, 143 | (5-formyl-5,6,7,8-tetrahydropteroyl)glutamate (6R,S)-5-Formyltetrahydrofolate 10-Formyl-7,8-dihydrofolate 10-Formyl-7,8-dihydrofolic acid 5-Formyl-5,6,7,8-tetrahydrofolate 5-Formyl-5,6,7,8-tetrahydrofolic acid 5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid 5-Formyltetrahydrofolate 5-Formyltetrahydrofolic acid 5-Formyltetrahydropteroylglutamate 5-Formyltetrahydropteroylglutamic acid 5-formyltetrahydrofolic acid Acide folinique Calcium citrovorum factor Calcium folinate Citrovorum factor Folinate Folinic acid Folinic acid calcium salt | Folinic acid calcium salt USP27 Folinic acid-SF L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid L-Leucovorin L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid L-leucovorin Leucal Leucovorin calcium Leucovorin folinic acid Leucovorinum Leukovorin Levoleucovorin N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid N5-Formyl-5,6,7,8-tetrahydrofolate N5-Formyl-5,6,7,8-tetrahydrofolic acid N5-Formyl-THF N5-Formyltetrahydrofolate N5-Formyltetrahydrofolic acid Welcovorin Wellcovorin folinate |
| | 34 | | Folic Acid | approved, nutraceutical, vet_approved | Phase 2 | 4392 | 59-30-3 | 6037 | (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid 01769_FLUKA 2d0k 33609-88-0 36653-55-1 (mono-potassium salt) 59-30-3 6484-89-5 (mono-hydrochloride salt) AC-11682 AC1L1LNX AI3-26387 AKOS000503224 ARONIS014410 Acfol (Spain) Acide folique Acide folique [INN-French] Acido folico Acido folico [INN-Spanish] Acidum folicum Acidum folicum [INN-Latin] Acifolic Antianemia factor Apo-Folic BIDD:ER0563 BIDD:GT0641 BIF0608 BPBio1_000654 BSPBio_000594 BSPBio_002338 C00504 C20H20N6O6 CAS-59-30-3 CCRIS 666 CHEBI:27470 CHEMBL1622 CID6037 CPD000471860 Cytofol D00070 DB00158 DivK1c_000494 Dosfolat B activ EINECS 200-419-0 F0043 F7876_SIAL F7876_SIGMA F8758_SIGMA F8798_SIAL F8890_SIGMA FOL Facid Factor U Folacid Folacin Folaemin Folaemin [Netherlands] Folan Folasic (Australia) Folate Folbal Folcidin Folcidin (VAN) Folcysteine Foldine Foldine [France] Folettes Foliamin Folic Folic acid Folic acid (JP15/USP/INN) Folic acid (TN) Folic acid [BAN:INN:JAN] Folic acid [INN:BAN:JAN] Folic acid dihydrate Folicet Folicet (TN) Folico Folico (Italy) Folina Folina (Italy) Folipac Folsaeure | Folsan Folsaure Folsav Folvite Folvron Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L HMS1921D20 HMS2092N17 HMS501I16 HSDB 2002 IDI1_000494 InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s Incafolic KBio1_000494 KBio2_001861 KBio2_004429 KBio2_006997 KBio3_001558 KBioGR_002222 KBioSS_001861 Kyselina listova Kyselina listova [Czech] LS-2157 Liver Lactobacillus casei factor MLS001304016 MLS001335861 Millafol Mission prenatal Mittafol MolPort-004-285-551 N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-Pteroyl-L-glutamic acid N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid NCGC00016265-01 NCGC00142391-01 NINDS_000494 NSC 3073 Nifolin Nifolin [Denmark] Novofolacid Novofolacid [Canada] PGA PGA (VAN) Prestwick3_000627 Prestwick_230 PteGlu Pteroyl-L-glutamate Pteroyl-L-glutamic acid Pteroyl-L-monoglutamate Pteroyl-L-monoglutamic acid Pteroylglutamate Pteroylglutamic acid Pteroylmonoglutamate Pteroylmonoglutamic acid SAM002264616 SDCCGMLS-0066738.P001 SMP2_000137 SMR000471860 SPBio_001357 SPECTRUM1502020 Serum Folate Level Spectrum2_001459 Spectrum3_000749 Spectrum4_001751 Spectrum5_000602 Spectrum_001381 UNII-935E97BOY8 Usaf cb-13 Vitamin B11 Vitamin B9 Vitamin Bc Vitamin Be Vitamin M bmse000299 folic acid nchembio.108-comp10 | |
| | 35 | | tannic acid | approved, Nutraceutical | Phase 2 | 2016 | | | | 36 | | Substance P | investigational | Phase 2 | 249 | 33507-63-0 | 44359816 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
| | 37 | | Neurotransmitter Agents | | Phase 2 | 18340 | | | | 38 | | Botulinum Toxins | | Phase 2 | 697 | | | | 39 | | Anesthetics | | Phase 2, Phase 1 | 9596 | | | | 40 | | abobotulinumtoxinA | | Phase 2 | 652 | | | | 41 | | Botulinum Toxins, Type A | | Phase 2 | 657 | | | | 42 | | Cholinergic Agents | | Phase 2 | 3992 | | | | 43 | | onabotulinumtoxinA | | Phase 2 | 652 | | | | 44 | | Pharmaceutical Solutions | | Phase 2 | 8192 | | | | 45 | | Neuromuscular Agents | | Phase 2 | 1180 | | | | 46 | | incobotulinumtoxinA | | Phase 2 | 662 | | | | 47 | | Photosensitizing Agents | | Phase 2 | 492 | | | | 48 | | Folic Acid Antagonists | | Phase 2 | 2257 | | | | 49 | | Cytochrome P-450 Enzyme Inhibitors | | Phase 2 | 3917 | | | | 50 | | Renal Agents | | Phase 2 | 754 | | |
Interventional clinical trials: (show top 50)
(show all 60)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Randomised Double Blind Crossover Placebo Controlled Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa | Unknown status | NCT00336154 | Phase 4 | | 2 | Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa | Completed | NCT00231517 | Phase 4 | | 3 | A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa | Terminated | NCT01619670 | Phase 4 | | 4 | Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin | Unknown status | NCT01340235 | Phase 3 | | 5 | Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa | Recruiting | NCT03068780 | Phase 3 | | 6 | A Comparative Study of the Healing of Chronic Ulcers of Recessive Epidermolysis Bullosa : Dressing vs Amniotic Membrane | Recruiting | NCT02286427 | Phase 3 | | 7 | ESSENCE Study: Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa | Active, not recruiting | NCT02384460 | Phase 3 | | 8 | A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing | Terminated | NCT01749306 | Phase 3 | | 9 | Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB) | Terminated | NCT00587223 | Phase 3 | | 10 | Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita | Unknown status | NCT00936533 | Phase 2 | | 11 | Study of Alwextin® Cream in Treating Epidermolysis Bullosa | Completed | NCT00825565 | Phase 2 | | 12 | Case Series Documentation of Patients With Epidermolysis Bullosa | Completed | NCT01294241 | Phase 2 | | 13 | The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa | Completed | NCT00380640 | Phase 2 | | 14 | Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa | Completed | NCT02014376 | Phase 2 | | 15 | Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate) | Completed | NCT00951964 | Phase 2 | | 16 | Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa | Completed | NCT01538862 | Phase 2 | | 17 | Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita | Completed | NCT00004359 | Phase 2 | | 18 | Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa | Completed | NCT00987142 | Phase 2 | | 19 | Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa | Recruiting | NCT02579369 | Phase 1, Phase 2 | | 20 | Stem Cell Transplant for Epidermolysis Bullosa | Recruiting | NCT01033552 | Phase 2 | | 21 | Safety and Efficacy of Diacerein 1% Ointment Topical Formulation Compared to Placebo for Subjects With Epidermolysis Bullosa Simplex (EBS) | Recruiting | NCT03154333 | Phase 2 | | 22 | Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa Patients With Nonsense Mutations | Recruiting | NCT03012191 | Phase 1, Phase 2 | | 23 | Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa | Recruiting | NCT01263379 | Phase 1, Phase 2 | | 24 | MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs | Recruiting | NCT02582775 | Phase 2 | | 25 | A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB) | Recruiting | NCT02810951 | Phase 1, Phase 2 | | 26 | Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB. | Recruiting | NCT02984085 | Phase 1, Phase 2 | | 27 | Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients | Recruiting | NCT02654483 | Phase 2 | | 28 | Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study | Recruiting | NCT02960997 | Phase 2 | | 29 | Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study | Recruiting | NCT03016715 | Phase 2 | | 30 | Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa | Active, not recruiting | NCT02323789 | Phase 1, Phase 2 | | 31 | Diacerin for the Treatment of Epidermolysis Bullosa Simplex | Not yet recruiting | NCT02470689 | Phase 2 | | 32 | A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa | Terminated | NCT00311766 | Phase 2 | | 33 | A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa | Withdrawn | NCT01528306 | Phase 2 | | 34 | Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane in Patients With Epidermolysis Bullosa | Completed | NCT01908088 | Phase 1 | | 35 | Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa | Completed | NCT00014729 | Phase 1 | | 36 | Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa | Recruiting | NCT02793960 | Phase 1 | | 37 | Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa | Recruiting | NCT02493816 | Phase 1 | | 38 | Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin | Recruiting | NCT02592954 | Phase 1 | | 39 | Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) | Unknown status | NCT01874769 | | | 40 | Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB) | Unknown status | NCT00881556 | Early Phase 1 | | 41 | Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara | Completed | NCT01556308 | | | 42 | Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa | Completed | NCT00904163 | | | 43 | Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care | Completed | NCT01716169 | | | 44 | Establishment of the National Epidermolysis Bullosa Registry | Completed | NCT00004761 | | | 45 | Study of the Nutritional, Metabolic, and Body Composition Profile in Children and Adolescents With Epidermolysis Bullosa | Completed | NCT00004791 | | | 46 | Short Term Observational Study in DEB Patients | Completed | NCT02178969 | | | 47 | Study of Scaling Disorders and Other Inherited Skin Diseases | Completed | NCT00001292 | | | 48 | Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa | Recruiting | NCT01019148 | | | 49 | Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa | Recruiting | NCT03158662 | | | 50 | Study of Cellutome System for Treatment of Individual Lesions in EB Pts | Recruiting | NCT02670837 | |
Inferred drug relations via UMLS68/NDF-RT46: Show with subtypes
|
